Merck & Co., Inc. (0QAH.IL)

131,00 -0,40 (-0,30%) Börsenschluss: 07:13PM BST

Merck & Co., Inc.

126 East Lincoln Avenue
Rahway, NJ 07065
United States
908 740 4000
https://www.merck.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 67.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Robert M. Davis J.D.	Chairman, Pres & CEO	6,08M	6,77M	1967
Ms. Caroline Litchfield	Exec. VP & CFO	2,8M	N/A	1969
Ms. Jennifer L. Zachary	Exec. VP & Gen. Counsel	2,73M	3,46M	1978
Dr. Dean Y. Li M.D., Ph.D.	Exec. VP & Pres of Merck Research Laboratories	3,44M	N/A	1962
Mr. Chirfi Guindo	Sr. VP & Chief Marketing Officer for Merck Human Health	1,54M	N/A	1966
Mr. David Michael Williams	Exec. VP and Chief Information & Digital Officer	N/A	N/A	1969
Mr. Peter Dannenbaum	VP of Investor Relations	N/A	N/A	N/A
Lisa LeCointe-Cephas	Sr. VP and Chief Ethics & Compliance Officer	N/A	N/A	1982
Ms. Cristal N. Downing	Exec. VP and Chief Communications & Public Affairs Officer	N/A	N/A	1970
Mr. Steven C. Mizell	Exec. VP & Chief HR Officer	N/A	N/A	1960

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors, as well as a clinical trial collaboration and supply agreement with Phanes Therapeutics, Inc. to evaluate PT886 in combination with KEYTRUDA for the treatment of claudin 18.2 positive gastric or gastroesophageal junction adenocarcinomas, as well as a development and commercialization agreement with Daiichi Sankyo Company, Limited to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Corporate Governance

Merck & Co., Inc.s ISS Governance QualityScore, Stand 1. Oktober 2023, lautet 4. Die grundlegenden Scores sind Audit: 6, Vorstand: 6, Shareholderrechte: 3, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.